ABT vs. BMY: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABT and BMY, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABT dominates in value with a market cap of 231.49 billion USD, eclipsing BMY’s 95.18 billion USD by roughly 2.43×.
ABT’s beta of 0.74 points to much larger expected swings compared to BMY’s calmer 0.40, suggesting both higher upside and downside potential.
| Symbol | ABT | BMY |
|---|---|---|
| Company Name | Abbott Laboratories | Bristol-Myers Squibb Company |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Drug Manufacturers - General |
| CEO | Mr. Robert B. Ford | Dr. Christopher S. Boerner Ph.D. |
| Price | 133.05 USD | 46.77 USD |
| Market Cap | 231.49 billion USD | 95.18 billion USD |
| Beta | 0.74 | 0.40 |
| Exchange | NYSE | NYSE |
| IPO Date | March 17, 1980 | June 1, 1972 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABT and BMY over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ABT and BMY based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- BMY shows a negative forward PEG of -3.01, signaling expected earnings contraction, while ABT at 1.73 maintains analysts’ projections for stable or improved profits.
| Symbol | ABT | BMY |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 17.22 | 17.53 |
| Forward PEG Ratio (TTM) | 1.73 | -3.01 |
| Price-to-Sales Ratio (P/S, TTM) | 5.47 | 2.00 |
| Price-to-Book Ratio (P/B, TTM) | 2.48 | 5.46 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 34.77 | 7.27 |
| EV-to-EBITDA (TTM) | 22.97 | 8.38 |
| EV-to-Sales (TTM) | 5.63 | 2.85 |
| EV-to-Free Cash Flow (TTM) | 35.78 | 10.36 |
Dividend Comparison
BMY stands out with a 5.22% dividend yield—around 204% above ABT’s 1.71%—highlighting its emphasis on generous payouts.
| Symbol | ABT | BMY |
|---|---|---|
| Dividend Yield (TTM) | 1.71% | 5.22% |
Financial Strength Metrics Comparison
Explore the financial strength details for ABT and BMY in the table below.
| Symbol | ABT | BMY |
|---|---|---|
| Current Ratio (TTM) | 1.78 | 1.28 |
| Quick Ratio (TTM) | 1.27 | 1.17 |
| Debt-to-Equity Ratio (TTM) | 0.14 | 2.95 |
| Debt-to-Assets Ratio (TTM) | 0.16 | 0.55 |
| Interest Coverage Ratio (TTM) | 15.39 | 4.36 |